PI3K/Akt and Nrf2/HO-1 pathways involved in the hepatoprotective effect of verapamil against thioacetamide toxicity in rats

Liver is a precious organ to maintain body life. Hepatotoxicity is a worldwide health problem that is still a challenge for research. Although countless pharmaceutical drugs and herbal compounds were screened for their hepatoprotective effects, the death from hepatotoxicity is increasing. Thus, ther...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Human & experimental toxicology 2019-04, Vol.38 (4), p.381-388
Hauptverfasser: Mohamed, MZ, Hafez, HM, Hassan, M, Ibrahim, MA
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext bestellen
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page 388
container_issue 4
container_start_page 381
container_title Human & experimental toxicology
container_volume 38
creator Mohamed, MZ
Hafez, HM
Hassan, M
Ibrahim, MA
description Liver is a precious organ to maintain body life. Hepatotoxicity is a worldwide health problem that is still a challenge for research. Although countless pharmaceutical drugs and herbal compounds were screened for their hepatoprotective effects, the death from hepatotoxicity is increasing. Thus, there is continuous necessity of searching for the hepatoprotective effect of commonly used drugs. Accordingly, our aim was to examine a hepatoprotective potential for the antihypertensive drug, verapamil, and searching for new insights underlie its protective mechanism. Four groups of adult male rats were randomly arranged as controls, thioacetamide (TAA) hepatotoxic, and TAA + verapamil treated. Serum liver enzyme, hepatic antioxidant, lipid peroxidation, and inflammatory parameters were assessed. Gene relative expression for heme oxygenase-1 (HO-1), nuclear factor-erythroid 2-related factor 2 (Nrf2), phosphoinositide 3-kinase (PI3K), and serine/threonine-specific protein kinase (Akt) were quantified in hepatic tissue. TAA caused hepatic injury evident both histopathologically and biochemically by a decrease in all gene expressions. Verapamil alleviated the injury via its antioxidant and anti-inflammatory effects that were suggested to be via upregulation of the previous gene expressions. In conclusion, the calcium channel blocker, verapamil, that is used widely as antihypertensive exhibits a valuable hepatoprotective effect. The protection partially rests on activation of Nrf2/HO-1 and PI3K/Akt pathways.
doi_str_mv 10.1177/0960327118817099
format Article
fullrecord <record><control><sourceid>proquest_AFRWT</sourceid><recordid>TN_cdi_proquest_journals_2195194109</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sage_id>10.1177_0960327118817099</sage_id><sourcerecordid>2195194109</sourcerecordid><originalsourceid>FETCH-LOGICAL-c365t-1b0459300f57d30b15813d723b07027461788a52d549d5f5d71ffaf3d2acc023</originalsourceid><addsrcrecordid>eNp1UEtPAjEQboxGEL17Mk08r8y02-32SIyvaNSD903ZtrAILLYFJf55S0BNTDzNZL7X5CPkFOECUco-qAI4k4hliRKU2iNdzKXMQAHfJ90NnG3wDjkKYQIAhRJ4SDocBCtAii75fL7j9_3Ba6R6buijd6x_-5QhXeg4ftfrQJv5qp2urEkLjWNLxzZB7cK30daxWVlqnUsbbR1dWa8XetZMqR7pZh5iEjStrm1MR2NpbD-auonrjZXXMRyTA6enwZ7sZo-8XF-9XN5mD083d5eDh6zmhYgZDiEXigM4IQ2HIYoSuZGMD0ECk3mBsiy1YEbkyggnjETntOOG6boGxnvkfGubnn5b2hCrSbv085RYMUx9qBxBJRZsWbVvQ_DWVQvfzLRfVwjVpuzqb9lJcrYzXg5n1vwIvttNhGxLCHpkf1P_NfwCHDaF4w</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>2195194109</pqid></control><display><type>article</type><title>PI3K/Akt and Nrf2/HO-1 pathways involved in the hepatoprotective effect of verapamil against thioacetamide toxicity in rats</title><source>Sage Journals GOLD Open Access 2024</source><creator>Mohamed, MZ ; Hafez, HM ; Hassan, M ; Ibrahim, MA</creator><creatorcontrib>Mohamed, MZ ; Hafez, HM ; Hassan, M ; Ibrahim, MA</creatorcontrib><description>Liver is a precious organ to maintain body life. Hepatotoxicity is a worldwide health problem that is still a challenge for research. Although countless pharmaceutical drugs and herbal compounds were screened for their hepatoprotective effects, the death from hepatotoxicity is increasing. Thus, there is continuous necessity of searching for the hepatoprotective effect of commonly used drugs. Accordingly, our aim was to examine a hepatoprotective potential for the antihypertensive drug, verapamil, and searching for new insights underlie its protective mechanism. Four groups of adult male rats were randomly arranged as controls, thioacetamide (TAA) hepatotoxic, and TAA + verapamil treated. Serum liver enzyme, hepatic antioxidant, lipid peroxidation, and inflammatory parameters were assessed. Gene relative expression for heme oxygenase-1 (HO-1), nuclear factor-erythroid 2-related factor 2 (Nrf2), phosphoinositide 3-kinase (PI3K), and serine/threonine-specific protein kinase (Akt) were quantified in hepatic tissue. TAA caused hepatic injury evident both histopathologically and biochemically by a decrease in all gene expressions. Verapamil alleviated the injury via its antioxidant and anti-inflammatory effects that were suggested to be via upregulation of the previous gene expressions. In conclusion, the calcium channel blocker, verapamil, that is used widely as antihypertensive exhibits a valuable hepatoprotective effect. The protection partially rests on activation of Nrf2/HO-1 and PI3K/Akt pathways.</description><identifier>ISSN: 0960-3271</identifier><identifier>EISSN: 1477-0903</identifier><identifier>DOI: 10.1177/0960327118817099</identifier><identifier>PMID: 30526075</identifier><language>eng</language><publisher>London, England: SAGE Publications</publisher><subject>1-Phosphatidylinositol 3-kinase ; AKT protein ; Animals ; Anti-Inflammatory Agents - pharmacology ; Anti-Inflammatory Agents - therapeutic use ; Antihypertensives ; Antioxidants ; Antioxidants - pharmacology ; Antioxidants - therapeutic use ; Calcium ; Calcium channel blockers ; Calcium Channel Blockers - pharmacology ; Calcium Channel Blockers - therapeutic use ; Chemical and Drug Induced Liver Injury - drug therapy ; Chemical and Drug Induced Liver Injury - genetics ; Chemical and Drug Induced Liver Injury - pathology ; Drugs ; Gene expression ; Heme ; Heme oxygenase (decyclizing) ; Heme Oxygenase (Decyclizing) - genetics ; Hepatotoxicity ; Inflammation ; Kinases ; Lipid peroxidation ; Lipids ; Liver ; Liver - drug effects ; Liver - metabolism ; Liver - pathology ; Male ; NF-E2-Related Factor 2 - genetics ; Oxygenase ; Peroxidation ; Phosphatidylinositol 3-Kinases - genetics ; Protein kinase ; Proteins ; Proto-Oncogene Proteins c-akt - genetics ; Rats ; Rodents ; Searching ; Signal Transduction ; Thioacetamide ; Threonine ; Toxicity ; Verapamil ; Verapamil - pharmacology ; Verapamil - therapeutic use</subject><ispartof>Human &amp; experimental toxicology, 2019-04, Vol.38 (4), p.381-388</ispartof><rights>The Author(s) 2018</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c365t-1b0459300f57d30b15813d723b07027461788a52d549d5f5d71ffaf3d2acc023</citedby><cites>FETCH-LOGICAL-c365t-1b0459300f57d30b15813d723b07027461788a52d549d5f5d71ffaf3d2acc023</cites><orcidid>0000-0003-4246-210X</orcidid></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://journals.sagepub.com/doi/pdf/10.1177/0960327118817099$$EPDF$$P50$$Gsage$$H</linktopdf><linktohtml>$$Uhttps://journals.sagepub.com/doi/10.1177/0960327118817099$$EHTML$$P50$$Gsage$$H</linktohtml><link.rule.ids>314,780,784,21966,27853,27924,27925,44945,45333</link.rule.ids><linktorsrc>$$Uhttps://journals.sagepub.com/doi/full/10.1177/0960327118817099?utm_source=summon&amp;utm_medium=discovery-provider$$EView_record_in_SAGE_Publications$$FView_record_in_$$GSAGE_Publications</linktorsrc><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/30526075$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Mohamed, MZ</creatorcontrib><creatorcontrib>Hafez, HM</creatorcontrib><creatorcontrib>Hassan, M</creatorcontrib><creatorcontrib>Ibrahim, MA</creatorcontrib><title>PI3K/Akt and Nrf2/HO-1 pathways involved in the hepatoprotective effect of verapamil against thioacetamide toxicity in rats</title><title>Human &amp; experimental toxicology</title><addtitle>Hum Exp Toxicol</addtitle><description>Liver is a precious organ to maintain body life. Hepatotoxicity is a worldwide health problem that is still a challenge for research. Although countless pharmaceutical drugs and herbal compounds were screened for their hepatoprotective effects, the death from hepatotoxicity is increasing. Thus, there is continuous necessity of searching for the hepatoprotective effect of commonly used drugs. Accordingly, our aim was to examine a hepatoprotective potential for the antihypertensive drug, verapamil, and searching for new insights underlie its protective mechanism. Four groups of adult male rats were randomly arranged as controls, thioacetamide (TAA) hepatotoxic, and TAA + verapamil treated. Serum liver enzyme, hepatic antioxidant, lipid peroxidation, and inflammatory parameters were assessed. Gene relative expression for heme oxygenase-1 (HO-1), nuclear factor-erythroid 2-related factor 2 (Nrf2), phosphoinositide 3-kinase (PI3K), and serine/threonine-specific protein kinase (Akt) were quantified in hepatic tissue. TAA caused hepatic injury evident both histopathologically and biochemically by a decrease in all gene expressions. Verapamil alleviated the injury via its antioxidant and anti-inflammatory effects that were suggested to be via upregulation of the previous gene expressions. In conclusion, the calcium channel blocker, verapamil, that is used widely as antihypertensive exhibits a valuable hepatoprotective effect. The protection partially rests on activation of Nrf2/HO-1 and PI3K/Akt pathways.</description><subject>1-Phosphatidylinositol 3-kinase</subject><subject>AKT protein</subject><subject>Animals</subject><subject>Anti-Inflammatory Agents - pharmacology</subject><subject>Anti-Inflammatory Agents - therapeutic use</subject><subject>Antihypertensives</subject><subject>Antioxidants</subject><subject>Antioxidants - pharmacology</subject><subject>Antioxidants - therapeutic use</subject><subject>Calcium</subject><subject>Calcium channel blockers</subject><subject>Calcium Channel Blockers - pharmacology</subject><subject>Calcium Channel Blockers - therapeutic use</subject><subject>Chemical and Drug Induced Liver Injury - drug therapy</subject><subject>Chemical and Drug Induced Liver Injury - genetics</subject><subject>Chemical and Drug Induced Liver Injury - pathology</subject><subject>Drugs</subject><subject>Gene expression</subject><subject>Heme</subject><subject>Heme oxygenase (decyclizing)</subject><subject>Heme Oxygenase (Decyclizing) - genetics</subject><subject>Hepatotoxicity</subject><subject>Inflammation</subject><subject>Kinases</subject><subject>Lipid peroxidation</subject><subject>Lipids</subject><subject>Liver</subject><subject>Liver - drug effects</subject><subject>Liver - metabolism</subject><subject>Liver - pathology</subject><subject>Male</subject><subject>NF-E2-Related Factor 2 - genetics</subject><subject>Oxygenase</subject><subject>Peroxidation</subject><subject>Phosphatidylinositol 3-Kinases - genetics</subject><subject>Protein kinase</subject><subject>Proteins</subject><subject>Proto-Oncogene Proteins c-akt - genetics</subject><subject>Rats</subject><subject>Rodents</subject><subject>Searching</subject><subject>Signal Transduction</subject><subject>Thioacetamide</subject><subject>Threonine</subject><subject>Toxicity</subject><subject>Verapamil</subject><subject>Verapamil - pharmacology</subject><subject>Verapamil - therapeutic use</subject><issn>0960-3271</issn><issn>1477-0903</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2019</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNp1UEtPAjEQboxGEL17Mk08r8y02-32SIyvaNSD903ZtrAILLYFJf55S0BNTDzNZL7X5CPkFOECUco-qAI4k4hliRKU2iNdzKXMQAHfJ90NnG3wDjkKYQIAhRJ4SDocBCtAii75fL7j9_3Ba6R6buijd6x_-5QhXeg4ftfrQJv5qp2urEkLjWNLxzZB7cK30daxWVlqnUsbbR1dWa8XetZMqR7pZh5iEjStrm1MR2NpbD-auonrjZXXMRyTA6enwZ7sZo-8XF-9XN5mD083d5eDh6zmhYgZDiEXigM4IQ2HIYoSuZGMD0ECk3mBsiy1YEbkyggnjETntOOG6boGxnvkfGubnn5b2hCrSbv085RYMUx9qBxBJRZsWbVvQ_DWVQvfzLRfVwjVpuzqb9lJcrYzXg5n1vwIvttNhGxLCHpkf1P_NfwCHDaF4w</recordid><startdate>201904</startdate><enddate>201904</enddate><creator>Mohamed, MZ</creator><creator>Hafez, HM</creator><creator>Hassan, M</creator><creator>Ibrahim, MA</creator><general>SAGE Publications</general><general>Sage Publications Ltd</general><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7ST</scope><scope>7TK</scope><scope>7U7</scope><scope>C1K</scope><scope>K9.</scope><scope>NAPCQ</scope><scope>SOI</scope><orcidid>https://orcid.org/0000-0003-4246-210X</orcidid></search><sort><creationdate>201904</creationdate><title>PI3K/Akt and Nrf2/HO-1 pathways involved in the hepatoprotective effect of verapamil against thioacetamide toxicity in rats</title><author>Mohamed, MZ ; Hafez, HM ; Hassan, M ; Ibrahim, MA</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c365t-1b0459300f57d30b15813d723b07027461788a52d549d5f5d71ffaf3d2acc023</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2019</creationdate><topic>1-Phosphatidylinositol 3-kinase</topic><topic>AKT protein</topic><topic>Animals</topic><topic>Anti-Inflammatory Agents - pharmacology</topic><topic>Anti-Inflammatory Agents - therapeutic use</topic><topic>Antihypertensives</topic><topic>Antioxidants</topic><topic>Antioxidants - pharmacology</topic><topic>Antioxidants - therapeutic use</topic><topic>Calcium</topic><topic>Calcium channel blockers</topic><topic>Calcium Channel Blockers - pharmacology</topic><topic>Calcium Channel Blockers - therapeutic use</topic><topic>Chemical and Drug Induced Liver Injury - drug therapy</topic><topic>Chemical and Drug Induced Liver Injury - genetics</topic><topic>Chemical and Drug Induced Liver Injury - pathology</topic><topic>Drugs</topic><topic>Gene expression</topic><topic>Heme</topic><topic>Heme oxygenase (decyclizing)</topic><topic>Heme Oxygenase (Decyclizing) - genetics</topic><topic>Hepatotoxicity</topic><topic>Inflammation</topic><topic>Kinases</topic><topic>Lipid peroxidation</topic><topic>Lipids</topic><topic>Liver</topic><topic>Liver - drug effects</topic><topic>Liver - metabolism</topic><topic>Liver - pathology</topic><topic>Male</topic><topic>NF-E2-Related Factor 2 - genetics</topic><topic>Oxygenase</topic><topic>Peroxidation</topic><topic>Phosphatidylinositol 3-Kinases - genetics</topic><topic>Protein kinase</topic><topic>Proteins</topic><topic>Proto-Oncogene Proteins c-akt - genetics</topic><topic>Rats</topic><topic>Rodents</topic><topic>Searching</topic><topic>Signal Transduction</topic><topic>Thioacetamide</topic><topic>Threonine</topic><topic>Toxicity</topic><topic>Verapamil</topic><topic>Verapamil - pharmacology</topic><topic>Verapamil - therapeutic use</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Mohamed, MZ</creatorcontrib><creatorcontrib>Hafez, HM</creatorcontrib><creatorcontrib>Hassan, M</creatorcontrib><creatorcontrib>Ibrahim, MA</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>Environment Abstracts</collection><collection>Neurosciences Abstracts</collection><collection>Toxicology Abstracts</collection><collection>Environmental Sciences and Pollution Management</collection><collection>ProQuest Health &amp; Medical Complete (Alumni)</collection><collection>Nursing &amp; Allied Health Premium</collection><collection>Environment Abstracts</collection><jtitle>Human &amp; experimental toxicology</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext_linktorsrc</fulltext></delivery><addata><au>Mohamed, MZ</au><au>Hafez, HM</au><au>Hassan, M</au><au>Ibrahim, MA</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>PI3K/Akt and Nrf2/HO-1 pathways involved in the hepatoprotective effect of verapamil against thioacetamide toxicity in rats</atitle><jtitle>Human &amp; experimental toxicology</jtitle><addtitle>Hum Exp Toxicol</addtitle><date>2019-04</date><risdate>2019</risdate><volume>38</volume><issue>4</issue><spage>381</spage><epage>388</epage><pages>381-388</pages><issn>0960-3271</issn><eissn>1477-0903</eissn><abstract>Liver is a precious organ to maintain body life. Hepatotoxicity is a worldwide health problem that is still a challenge for research. Although countless pharmaceutical drugs and herbal compounds were screened for their hepatoprotective effects, the death from hepatotoxicity is increasing. Thus, there is continuous necessity of searching for the hepatoprotective effect of commonly used drugs. Accordingly, our aim was to examine a hepatoprotective potential for the antihypertensive drug, verapamil, and searching for new insights underlie its protective mechanism. Four groups of adult male rats were randomly arranged as controls, thioacetamide (TAA) hepatotoxic, and TAA + verapamil treated. Serum liver enzyme, hepatic antioxidant, lipid peroxidation, and inflammatory parameters were assessed. Gene relative expression for heme oxygenase-1 (HO-1), nuclear factor-erythroid 2-related factor 2 (Nrf2), phosphoinositide 3-kinase (PI3K), and serine/threonine-specific protein kinase (Akt) were quantified in hepatic tissue. TAA caused hepatic injury evident both histopathologically and biochemically by a decrease in all gene expressions. Verapamil alleviated the injury via its antioxidant and anti-inflammatory effects that were suggested to be via upregulation of the previous gene expressions. In conclusion, the calcium channel blocker, verapamil, that is used widely as antihypertensive exhibits a valuable hepatoprotective effect. The protection partially rests on activation of Nrf2/HO-1 and PI3K/Akt pathways.</abstract><cop>London, England</cop><pub>SAGE Publications</pub><pmid>30526075</pmid><doi>10.1177/0960327118817099</doi><tpages>8</tpages><orcidid>https://orcid.org/0000-0003-4246-210X</orcidid></addata></record>
fulltext fulltext_linktorsrc
identifier ISSN: 0960-3271
ispartof Human & experimental toxicology, 2019-04, Vol.38 (4), p.381-388
issn 0960-3271
1477-0903
language eng
recordid cdi_proquest_journals_2195194109
source Sage Journals GOLD Open Access 2024
subjects 1-Phosphatidylinositol 3-kinase
AKT protein
Animals
Anti-Inflammatory Agents - pharmacology
Anti-Inflammatory Agents - therapeutic use
Antihypertensives
Antioxidants
Antioxidants - pharmacology
Antioxidants - therapeutic use
Calcium
Calcium channel blockers
Calcium Channel Blockers - pharmacology
Calcium Channel Blockers - therapeutic use
Chemical and Drug Induced Liver Injury - drug therapy
Chemical and Drug Induced Liver Injury - genetics
Chemical and Drug Induced Liver Injury - pathology
Drugs
Gene expression
Heme
Heme oxygenase (decyclizing)
Heme Oxygenase (Decyclizing) - genetics
Hepatotoxicity
Inflammation
Kinases
Lipid peroxidation
Lipids
Liver
Liver - drug effects
Liver - metabolism
Liver - pathology
Male
NF-E2-Related Factor 2 - genetics
Oxygenase
Peroxidation
Phosphatidylinositol 3-Kinases - genetics
Protein kinase
Proteins
Proto-Oncogene Proteins c-akt - genetics
Rats
Rodents
Searching
Signal Transduction
Thioacetamide
Threonine
Toxicity
Verapamil
Verapamil - pharmacology
Verapamil - therapeutic use
title PI3K/Akt and Nrf2/HO-1 pathways involved in the hepatoprotective effect of verapamil against thioacetamide toxicity in rats
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-03T21%3A54%3A02IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_AFRWT&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=PI3K/Akt%20and%20Nrf2/HO-1%20pathways%20involved%20in%20the%20hepatoprotective%20effect%20of%20verapamil%20against%20thioacetamide%20toxicity%20in%20rats&rft.jtitle=Human%20&%20experimental%20toxicology&rft.au=Mohamed,%20MZ&rft.date=2019-04&rft.volume=38&rft.issue=4&rft.spage=381&rft.epage=388&rft.pages=381-388&rft.issn=0960-3271&rft.eissn=1477-0903&rft_id=info:doi/10.1177/0960327118817099&rft_dat=%3Cproquest_AFRWT%3E2195194109%3C/proquest_AFRWT%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=2195194109&rft_id=info:pmid/30526075&rft_sage_id=10.1177_0960327118817099&rfr_iscdi=true